Surgery Partners Inc earnings beat by $0.04, revenue fell short of estimates

Surgery Partners Inc (SGRY) reported Q3 EPS of $0.16, beating estimates by $0.04, but revenue of $815.3M missed expectations. The stock is up 74.13% over the past 3 months and 64.95% year-over-year. According to InvestingPro, the company's financial health is rated as 'good performance'.

Original reporting
Published Nov 9, 2026, 10:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SGRY
Neutral
high confidence
Mentioned
$SGRY
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SGRYNeutralMed
01

Why it matters

Earnings beat may attract short‑term buying, but revenue miss could prompt caution among investors.

02

Market read

The earnings release offers a fresh data point for traders evaluating SGRY and comparable healthcare service stocks.

03

What to watch

Potential cost‑structure improvements or contract wins not disclosed could mitigate the revenue shortfall.

Relevance 7/10Novelty 7/10Timing: post‑market release, relevant for next trading day

Background

Surgery Partners Inc (NASDAQ:SGRY) provides outpatient surgery services. The company posted Q3 results with a modest EPS beat but revenue below consensus.

Company-level read

Ticker impact

$SGRYNeutralHigh confidence
Context

Surgery Partners Inc reported Q3 EPS of $0.16, beating estimates by $0.04, while revenue missed expectations.

Expected impact

likely modest upside as market prices in the earnings beat, tempered by revenue shortfall

Evidence & confidence

The beat is small and revenue fell short, so traders may see limited upside rather than a strong rally.

Market effects

Healthcare services earnings beat may lift peer sentiment, but revenue miss signals pricing pressure in the sector.

U.S. market focus, limited broader regional effect.

Low global relevance; impact confined to U.S. healthcare services stocks.

Counterpoint

Revenue miss could signal underlying demand weakness, suggesting a short‑term pullback despite the EPS beat.

Key entities

  • Surgery Partners Inc

    U.S. outpatient surgery services provider

Related articles

$SGRYMed

Surgery Partners: Q3 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q3 loss of $21.1 million, or 16 cents per share, with adjusted earnings of 16 cents per share. The company's revenue was $815.3 million. The Tennessee-based surgical facilities operator provided these financial results on Monday.

$SGRYHighAI 8/10

SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced re

$SGRYHighAI 9/10

Why is Surgery Partners (SGRY) stock rocketing higher today

Surgery Partners (SGRY) stock rose 12% after amending its merger agreement with HealthSpan Partners, increasing the buyout offer to $25 per share and valuing the company at up to $6.0 billion. The board unanimously recommends shareholders approve the revised deal, which includes potential additional cash ticking fees. The stock has seen significant volatility, gaining 70.3% year-to-date and setting a new 52-week high.